| | | | | | | | | A multicancer early detection (MCED) test could help clinicians address a cancer screening challenge: the lack of a recommended screening test for certain cancers. Results from a recent study examining how MCED testing could aid cancer screening are reported in a Mayo Clinic News article. |
|
|
|
| |
| | |
|
|
| | | | | | CMS has released preliminary 2027 Medicare Clinical Laboratory Fee Schedule rates, with changes expected to reduce payments over the next several years. The College of American Pathologists has responded to the rates, urging Congress to pass the RESULTS Act to reform the CLFS rate-setting process. |
|
|
|
| |
| | |
|
|
| | | | | | Werfen's Aptiva APS IgA Reagent has received FDA 510(k) clearance and CE Mark, completing the Aptiva APS testing portfolio for all three isotypes—IgA, IgG, and IgM—of anti-cardiolipin and anti-beta 2 glycoprotein 1 antibodies, aiding in primary and secondary APS diagnosis. |
|
|
|
| |
| | |
|
|
| | | | | | Explore how molecular point-of-care testing can complement laboratory-based respiratory testing, improve turnaround times, and support diagnostic stewardship. Learn key considerations for implementing molecular POC platforms and earn CE credit. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | Stephanie Mitchell, PhD, Senior Director of Infectious Disease and Microbiology at Beckman Coulter will join MLO’s editor in chief in a discussion on general disease management with a deeper dive into sexually transmitted infection (STI) screening and antimicrobial resistance (AMR) surveillance. |
|
|
|
| |
| | |
|
|
| | | | | | Every lab has its personalities, pressure points, and moments of unexpected teamwork. If your lab were a TV show, which would it most resemble? Take our poll and see which show gets your vote. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
